GHS — Danville, Pennsylvania

GHS is a clinical research site located in Danville, Pennsylvania, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

GHS has participated in 1 clinical trials.

Therapeutic areas: Endometrial Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GHS?

GHS has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GHS conducted?

GHS has 1 clinical trials on record. Their work covers Endometrial Cancer.

Is GHS accredited by Crixeo Health?

GHS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GHS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.